SCHEMBL20160888

SCHEMBL20160888

O=C(Nc1cnccc1Cl)C1CCCCC1

nearest known ligand 0.60

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ GSK3B P49841 2/20 0.60
▸ GSK3A P49840 1/20 0.60
▸ HDAC3 O15379 3/20 0.52
▸ HDAC1 Q13547 3/20 0.52
▸ HDAC2 Q92769 3/20 0.52
▸ GRM4 Q14833 1/20 0.50
▸ KMT2A Q03164 2/20 0.49
▸ CETP P11597 1/20 0.49
▸ MEN1 O00255 1/20 0.49
▸ MAPT P10636 2/20 0.48
▸ TSHR P16473 1/20 0.48
▸ NAMPT P43490 1/20 0.47
▸ HPGD P15428 2/20 0.47
▸ KDM4E B2RXH2 1/20 0.47
▸ GAA P10253 1/20 0.47
▸ PTPN1 P18031 1/20 0.46
▸ AAK1 Q2M2I8 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL18208874 0.99 GSK3B (0.59) GSK3BGSK3AHDAC3HDAC1HDAC2
SCHEMBL18216169 0.86 GSK3B (0.61) GSK3BGSK3AKMT2AMAPTTSHR
Hydrochloric Acid SCHEMBL18208234 0.85 GSK3B (0.60) GSK3BGSK3AKMT2AMAPT
SCHEMBL30785575 0.84 GAA (0.55) GSK3BHDAC3HDAC1HDAC2KMT2A
SCHEMBL18208167 0.82 GSK3B (0.58) GSK3BGSK3AKMT2AMAPT
SCHEMBL18208170 0.82 GSK3B (0.58) GSK3BGSK3AKMT2AMAPT
SCHEMBL16568954 0.79 KMT2A (0.54) GSK3BHDAC3HDAC1HDAC2KMT2A
SCHEMBL29856319 0.78 MAPT (0.62) GSK3BHDAC3HDAC1HDAC2KMT2A
SCHEMBL20138846 0.76 GSK3A (0.56) GSK3BGSK3AGRM4KMT2AMAPT
SCHEMBL20138847 0.76 GSK3A (0.56) GSK3BGSK3AGRM4KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018087126-A1 AMIDO-SUBSTITUTED CYCLOHEXANE DERIVATIVES AS INHIBITORS OF TANKYRASE BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2018-05-17 — — WO disclosed
Send feedback